Kawano et al. were able to detect IL-6 production in freshly explanted human myelomas, and by using antibodies against IL-6, to specifically inhibit its pathway, they found a reduction in cellular proliferation, suggesting an autocrine requirement for this cytokine in this cell type for sustaining its proliferation [63]. The gene discussed is IL6; the disease is plasma cell myeloma.